Genomic presence of recombinant porcine endogenous retrovirus in transmitting miniature swine
© Martin et al; licensee BioMed Central Ltd. 2006
Received: 22 June 2006
Accepted: 02 November 2006
Published: 02 November 2006
The replication of porcine endogenous retrovirus (PERV) in human cell lines suggests a potential infectious risk in xenotransplantation. PERV isolated from human cells following cocultivation with porcine peripheral blood mononuclear cells is a recombinant of PERV-A and PERV-C. We describe two different recombinant PERV-AC sequences in the cellular DNA of some transmitting miniature swine. This is the first evidence of PERV-AC recombinant virus in porcine genomic DNA that may have resulted from autoinfection following exogenous viral recombination. Infectious risk in xenotransplantation will be defined by the activity of PERV loci in vivo.
Xenotransplantation using inbred miniature swine is a proposed solution to the shortage of organs available for transplantation. Three subgroups of porcine endogenous retroviruses (PERV) have been identified, PERV-A, -B, and -C. PERV-A and PERV-B have been shown to replicate in human cells in vitro, while PERV-C is largely restricted to porcine cells [1–5]. Infection of human subjects has not been identified in individuals with exposure to porcine tissue [3, 6–9], though concern about the risk of cross-species infection in xenotransplantation still exists.
It has been demonstrated that PERV replicating efficiently in human cells in vitro is a recombinant of PERV-A and -C within the env region, and probably arises from exogenous recombination of mRNA [2, 5, 10]. Following cocultivation of "transmitting" porcine peripheral blood mononuclear cells (PBMC) with human cell lines, PERV-AC recombinants have been identified within human cells in vitro [2, 4, 5]. PERV-AC recombinant provirus has not been detected previously in the genomes of transmitting swine [5, 10].
To examine the mechanisms underlying PERV recombination, four animals not known to transmit recombinant virus to human cells in vitro and four animals previously characterized as having a transmitting phenotype were identified from a herd of inbred miniature swine [5, 11]. Polymerase chain reaction (PCR) assays of tissue samples and coculture studies between porcine and human cells were undertaken to better characterize recombinant PERV in vivo.
Comparison of sequences from 13653 and 15150 revealed a 0.2% difference (3 out of 1284 base pairs). Comparison of sequences from 3 different tissues (spleen, liver, and PBMC in 13910 and spleen and PBMC in 15149) showed a difference of 0.4 – 1.2%. Some of these minute differences within multiple samples of the same tissues are within the realm of PCR and sequencing artifact, though the presence of actual small variations cannot be ruled out. Non-transmitting swine 15578, 15579, 16181, and 12190 revealed no evidence of genomic DNA PERV-AC recombinant virus in lymph node, liver, spleen, lung, thymus, or PBMC (animals 15578 and 15579) or just PBMC (12190).
These studies demonstrate the presence of recombinant PERV-AC in the DNA of four different transmitting swine. It is unclear whether the "transmitting" phenotype is a stable or intermittent trait and whether genomic PERV-AC sites are active. Wood et al. detected PERV-AC viral mRNA in unstimulated PBMC of transmitting animals; the sequences of these PERV recombinants were not compared with those derived from infected human cells . While the possibility exists that blood-derived elements account for the provirus we have detected in multiple tissues, previous studies did not demonstrate PERV-AC from PBMC of limited numbers of transmitting animals [5, 10].
Multiple PERV-AC recombinants have been described after in vitro infection of human cells. Episodic viral recombination might lead to the development of multiple strains of PERV-AC in a single animal, with autoinfection and with variable integration into cellular DNA of different tissues. The absence of virus from a single tissue (pancreas) in a transmitting animal with genomic PERV-AC is consistent with this hypothesis. However, enzymatic degradation of cellular DNA and RNA in pancreatic tissue or other factors might limit detection of PERV-AC in this organ. Of note, though, smaller fragments of control DNA from the cellular DNA harvested from pancreatic samples were still amplifiable by PCR (data not shown). The presence of two different types of PERV-AC in the cellular DNA of some transmitting animals suggests, however, that PERV recombination is intermittent and leaves behind genomic evidence of autoinfectious cycles.
The characterization of transmitting or non-transmitting phenotypes may not be permanent. This idea is consistent with the suggestion that the activity of PERV-C sites "drives" the recombination process . Further investigation is required to determine whether recombinant PERV can be derived from proviral DNA sites as well as from exogenous recombination of mRNA. In preliminary studies using stimulated PBMC from swine 15149 (transmitter) and 16181 (non-transmitter), transmission assays have not revealed infection of human 293 cells in vitro over 110 days of cocultivation. While the levels of PERV expression in these studies might be below the limit of detection, it is possible that the two genomic PERV-AC sequences detected here represent dysfunctional proviral elements.
The presence of PERV-AC in the DNA of porcine tissues from animals capable of transmitting infection to human cells combined with the early coculture assays sited above, suggest that the transmitting phenotype is intermittent. It remains to be determined whether the transmitting phenotype is inherited or acquired de novo in swine. It remains necessary to determine the conditions that determine the production of PERV-AC in vivo to determine the level of risk for infection of human recipients of porcine xenografts.
Materials and methods
Tissues were harvested from each animal, including blood, heart, lung, thymus, pancreas, liver, kidney, spleen, abdominal and thoracic lymph nodes, and skeletal muscle. Swine 15578, 15579, and 16181 were bred with a deletion of the gene encoding alpha-1, 3-galactosyltransferase and are considered non-transmitters. Cell samples from animal 12190 showed no transmission to either human or porcine cells in vitro, designating it a "null transmitter" . Care of animals was in accordance with the Guide for the Care and Use of Laboratory Animals prepared by the National Institutes of Health under a protocol approved by the Massachusetts General Hospital Subcommittee on Research Animal Care.
Tissues were stored at -80°C. DNA was isolated using the Puregene® DNA purification protocol (Gentra Systems, Minneapolis, MN) per manufacturer's instructions. For PCR amplification, PERV-A env primer VRBF (forward) (5'-CCTACCAGTTATAATCAATTTAATTATGGC-3') and two different PERV-C env reverse primers were used: TMR (5'-CTCAAACCACCCTTGAGTAGTTTCC-3') and PERV-C reverse (5'-TATGTTAGAGGATGGTCCTGGTC-3') as previously described [5, 12]. The presence of amplifiable porcine mitochondria cytochrome oxidase II was used as a DNA quality control. Forward primer (5'-TCACCCATCATAGAAGAACTCCTACA-3'), and reverse primer (5'-TTTTACGGTTAAGGCTGGGTTATTAATT-3') were used to amplify the mitochondrial DNA. Each PCR reaction involved 100 ng of isolated DNA. All PERV reactions were performed on a GeneAmp® PCR system 9700 (PE Applied Biosystems, Foster City, CA) with the following parameters: 94°C for 10 minutes, 40 cycles of 94°C for 30 seconds, 55°C for 30 seconds, and 72°C for 120 seconds, followed by 72°C for 10 minutes. For detection of porcine mitochondrial markers, an annealing/melting temperature of 60°C was used.
PCR products were isolated and cloned using the E. coli plasmid vector pCR4-TOPO® or pCR-XL-TOPO® (Invitrogen, Carlsbad, CA) per the manufacturer's instructions. Plasmids were isolated using QIAprep® Spin Miniprep columns (Qiagen, Valencia, CA). Sequencing was done with Applied Biosystems Taq DyeDeoxy Terminator cycle sequencing kits on an ABI 3700 PRISM automated sequencer (Massachusetts General Hospital DNA Core Sequencing facility).
Coculture assays were done using viable PBMC from animals 15149 and 16181.
PBMC were stimulated for 5 days in phytohemagglutinin and phorbol 12-myristate 13-acetate and then placed in tissue culture flasks together with target human 293 cells. Recombinant PERV-AC infection of human 293 cells was assayed using the PCR methods noted above on harvested cellular DNA from the human 293 cells on a once weekly, to once every two week basis.
This study was supported by Public Health Services grant NIH/NIAID 5T32-AI07529 and NIH-NIAID PO1-AI45897 (J.A.F., D.H.S.).
- Martin U, Winkler ME, Id M, Radeke H, Arseniev L, Takeuchi Y, Simon AR, Patience C, Haverich A, Steinhoff G: Productive infection of primary human endothelial cells by pig endogenous retrovirus. Xenotransplantation 2000,7(2):138-142. 10.1034/j.1399-3089.2000.00052.xView ArticlePubMedGoogle Scholar
- Oldmixon BA, Wood JC, Ericsson TA, Wilson CA, White-Scharf ME, Andersson G, Greenstein JL, Schuurman H, Patience C: Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J Virol 2002,76(6):3045-3048. 10.1128/JVI.76.6.3045-3048.2002PubMed CentralView ArticlePubMedGoogle Scholar
- Patience C, Takeuchi Y, Weiss RA: Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997,3(3):282-286. 10.1038/nm0397-282View ArticlePubMedGoogle Scholar
- Wilson CA, Wong S, Muller J, Davidson CE, Rose TM, Burd P: Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol 1998,72(4):3082-3087.PubMed CentralPubMedGoogle Scholar
- Wood JC, Quinn G, Suling KM, Oldmixon BA, Van Tine BA, Cina R, Arn S, Huang CA, Scobie L, Onions DE, Sachs DH, Schuurman H, Fishman JA, Patience C: Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature swine. J Virol 2004,78(5):2494-2501. 10.1128/JVI.78.5.2494-2501.2004PubMed CentralView ArticlePubMedGoogle Scholar
- Elliott RB, Escobar L, Garkavenko O, Croxson MC, Schroeder BA, McGregor M, Ferguson G, Beckman N, Ferguson S: No evidence of infection with porcine endogenous retrovirus in recipients of encapsulated porcine islet xenografts. Cell Transplant 2000,9(6):895-901.PubMedGoogle Scholar
- Paradis K, Langford G, Long Z, Heneine W, Sandstrom P, Switzer WM, Chapman LE, Lockey C, Onions D, Otto E: Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 1999,285(5431):1236-1241. 10.1126/science.285.5431.1236View ArticlePubMedGoogle Scholar
- Patience C, Patton GS, Takeuchi Y, Weiss RA, McClure MO, Rydberg L, Breimer ME: No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet 1998,352(9129):699-701. 10.1016/S0140-6736(98)04369-4View ArticlePubMedGoogle Scholar
- Sauer IM, Kardassis D, Zeillinger K, Pascher A, Gruenwald A, Pless G, Irgang M, Kraemer M, Puhl G, Frank J, Muller AR, Steinmuller T, Denner J, Neuhaus P, Gerlach JC: Clinical extracorporeal hybrid liver support: phase I study with primary porcine liver cells. Xenotransplantation 2003,10(5):460-469. 10.1034/j.1399-3089.2003.00062.xView ArticlePubMedGoogle Scholar
- Scobie L, Taylor S, Wood JC, Suling KM, Quinn G, Meikle S, Patience C, Schuurman H, Onions DE: Absence of replication-competent human-tropic porcine endogenous retroviruses in the germ line DNA of inbred miniature swine. J Virol 2004,78(5):2502-2509. 10.1128/JVI.78.5.2502-2509.2004PubMed CentralView ArticlePubMedGoogle Scholar
- Sachs DH, Leight G, Cone J, Schwarz S, Stuart L, Rosenberg S: Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. Transplantation 1976,22(6):559-567. 10.1097/00007890-197612000-00004View ArticlePubMedGoogle Scholar
- Takeuchi Y, Patience C, Magre S, Weiss RA, Banerjee PT, Le Tissier P, Stoyle JP: Host range and interference studies of three classes of pig endogenous retrovirus. J Virol 1998,72(12):9986-9991.PubMed CentralPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.